SLC5A2 and type 2 diabetes mellitus: The pathophysiology of SGLT2i-associated ketoacidosis is complex but likely involves inhibition of SGLT2 in the proximal renal tubules, which promotes glucosuria and thereby reduces plasma glucose levels [5].